These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 33722977)
1. α-Arrestin ARRDC3 tumor suppressor function is linked to GPCR-induced TAZ activation and breast cancer metastasis. Arakaki AKS; Pan WA; Wedegaertner H; Roca-Mercado I; Chinn L; Gujral TS; Trejo J J Cell Sci; 2021 Apr; 134(8):. PubMed ID: 33722977 [TBL] [Abstract][Full Text] [Related]
2. The α-arrestin ARRDC3 suppresses breast carcinoma invasion by regulating G protein-coupled receptor lysosomal sorting and signaling. Arakaki AKS; Pan WA; Lin H; Trejo J J Biol Chem; 2018 Mar; 293(9):3350-3362. PubMed ID: 29348172 [TBL] [Abstract][Full Text] [Related]
3. The α-Arrestin ARRDC3 Is an Emerging Multifunctional Adaptor Protein in Cancer. Wedegaertner H; Pan WA; Gonzalez CC; Gonzalez DJ; Trejo J Antioxid Redox Signal; 2022 May; 36(13-15):1066-1079. PubMed ID: 34465145 [No Abstract] [Full Text] [Related]
4. The α-arrestin ARRDC3 mediates ALIX ubiquitination and G protein-coupled receptor lysosomal sorting. Dores MR; Lin H; J Grimsey N; Mendez F; Trejo J Mol Biol Cell; 2015 Dec; 26(25):4660-73. PubMed ID: 26490116 [TBL] [Abstract][Full Text] [Related]
5. Divergent regulation of α-arrestin ARRDC3 function by ubiquitination. Wedegaertner H; Bosompra O; Kufareva I; Trejo J Mol Biol Cell; 2023 Aug; 34(9):ar93. PubMed ID: 37223976 [TBL] [Abstract][Full Text] [Related]
6. Arrestin Domain Containing 3 Reverses Epithelial to Mesenchymal Transition and Chemo-Resistance of TNBC Cells by Up-Regulating Expression of miR-200b. Soung YH; Chung H; Yan C; Ju J; Chung J Cells; 2019 Jul; 8(7):. PubMed ID: 31295851 [TBL] [Abstract][Full Text] [Related]
7. Transactivation of the PAR1-PAR2 heterodimer by thrombin elicits β-arrestin-mediated endosomal signaling. Lin H; Trejo J J Biol Chem; 2013 Apr; 288(16):11203-15. PubMed ID: 23476015 [TBL] [Abstract][Full Text] [Related]
8. Arrestin domain containing 3 promotes Helicobacter pylori-associated gastritis by regulating protease-activated receptor 1. Liu YG; Teng YS; Shan ZG; Cheng P; Hao CJ; Lv YP; Mao FY; Yang SM; Chen W; Zhao YL; You N; Zou QM; Zhuang Y JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32634127 [TBL] [Abstract][Full Text] [Related]
9. Termination of protease-activated receptor-1 signaling by beta-arrestins is independent of receptor phosphorylation. Chen CH; Paing MM; Trejo J J Biol Chem; 2004 Mar; 279(11):10020-31. PubMed ID: 14699102 [TBL] [Abstract][Full Text] [Related]
10. The α-Arrestin ARRDC3 Regulates the Endosomal Residence Time and Intracellular Signaling of the β2-Adrenergic Receptor. Tian X; Irannejad R; Bowman SL; Du Y; Puthenveedu MA; von Zastrow M; Benovic JL J Biol Chem; 2016 Jul; 291(28):14510-25. PubMed ID: 27226565 [TBL] [Abstract][Full Text] [Related]
11. Protease activated receptor-1 regulates mixed lineage kinase-3 to drive triple-negative breast cancer tumorigenesis. Srivastava P; Jha S; Singh SK; Vyas H; Sethupathi P; Nair RS; Ramachandran K; Rana B; Kumar S; Rana A Cancer Lett; 2024 Oct; 603():217200. PubMed ID: 39222677 [TBL] [Abstract][Full Text] [Related]
12. ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation. Xiao J; Shi Q; Li W; Mu X; Peng J; Li M; Chen M; Huang H; Wang C; Gao K; Fan J Am J Cancer Res; 2018; 8(1):132-143. PubMed ID: 29416926 [TBL] [Abstract][Full Text] [Related]
13. Selective Inhibitors of Nuclear Export (SINE) compounds block proliferation and migration of triple negative breast cancer cells by restoring expression of ARRDC3. Soung YH; Kashyap T; Nguyen T; Yadav G; Chang H; Landesman Y; Chung J Oncotarget; 2017 Aug; 8(32):52935-52947. PubMed ID: 28881784 [TBL] [Abstract][Full Text] [Related]
14. Twist-mediated PAR1 induction is required for breast cancer progression and metastasis by inhibiting Hippo pathway. Wang Y; Liao R; Chen X; Ying X; Chen G; Li M; Dong C Cell Death Dis; 2020 Jul; 11(7):520. PubMed ID: 32647142 [TBL] [Abstract][Full Text] [Related]
15. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244 [TBL] [Abstract][Full Text] [Related]
16. ARRDC3 suppresses colorectal cancer progression through destabilizing the oncoprotein YAP. Shen X; Sun X; Sun B; Li T; Wu G; Li Y; Chen L; Liu Q; Cui M; Zhou Z FEBS Lett; 2018 Feb; 592(4):599-609. PubMed ID: 29364502 [TBL] [Abstract][Full Text] [Related]
17. Baicalein promotes KDM4E to induce BICD1 and inhibit triple-negative breast cancer progression by blocking PAR1 signaling. Dong Y; He G; Chen K; He X; Pan M; Huang X; Yu X; Xia J Mol Carcinog; 2024 Jul; 63(7):1288-1302. PubMed ID: 38607237 [TBL] [Abstract][Full Text] [Related]
18. Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion. Arora P; Cuevas BD; Russo A; Johnson GL; Trejo J Oncogene; 2008 Jul; 27(32):4434-45. PubMed ID: 18372913 [TBL] [Abstract][Full Text] [Related]
19. Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through β-arrestin and dishevelled-2 scaffolds. Soh UJ; Trejo J Proc Natl Acad Sci U S A; 2011 Dec; 108(50):E1372-80. PubMed ID: 22106258 [TBL] [Abstract][Full Text] [Related]
20. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway. Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]